Beige fat dissipates energy and functions as a defense against cold and obesity, 34 but the underlying mechanisms remain unclear. We found that the signaling of 35 interleukin (IL)-25 including its cognate receptor, IL-17 receptor B (IL-17RB), 36 increased in adipose tissue upon cold and β3-adrenoceptor agonist stimulation. induced the browning effect in white adipose tissue (WAT) by releasing 13 and 38 promoting alternative activation of macrophages to regulate innervation, which 39 characterized as tyrosine hydroxylase (TH) up-regulation to produce more 40 catecholamine including norepinephrine. Blockade of IL-4Rα and depletion of 41 macrophages with clodronate-loaded liposomes in vivo significantly impaired the 42 browning of WAT. Obese mice administered with IL-25 were protected from obesity 43 on a high-fat diet and the subsequent metabolic disorders, and the process involved 44 the uncoupling protein 1 (UCP1)-mediated thermogenesis. In conclusion, the 45 activation of IL-25 signaling on beige fat might play a therapeutic potential for 46 obesity and its associated metabolic disorders.
intraperitoneally administered to normal control mice for 7 days. Figure 2A shows 150 that IL-25 increased the expression of UCP1 protein in scWAT, but not in BAT, in a 151 dose-dependent manner. As the expression of UCP1 also increased after a high dose 152 of IL-25 (1000ng/d) administered in eWAT (Figure 2A ), the dose of 1000ng/d for 153 IL-25 was applied in the following experiment. Furthermore, to validate the activity 154 of recombinant IL-25, its receptor, IL-17RB, was also examined and shown to be 155 up-regulated ( Figure 2B ). Western-blot and RT-qPCR analysis showed that IL-25 156 induced the expression of UCP1 ( Figure 2B and2C ). Histologic analysis showed that 157 beige fat was characterized as high expression of the specific mitochondrial UCP1 158 and multilocular morphology in scWAT and eWAT after IL-25 treatment ( Figure 2D 159 and 2E). These data suggested that IL-25 stimulated the development of beige fat. 160 We next analyzed whether IL-25 could suppress the expression of 161 pro-inflammatory genes and increase the expression of anti-inflammatory genes in 162 diet-induced-obesity (DIO) chronic inflammatory adipose tissue. Figure 2F shows that 163 5 IL-25 promoted the expression of anti-inflammatory cytokines such as IL-10 and 164 IL-13 and decreased the expression of pro-inflammatory cytokines such as IFN-γ, 165 IL-1β and IL-6. 166 Next, to further explore the mechanism of IL-25-induced beige, recombinant 167 IL-25 was applied to treat the differentiated 3T3-L1 MBX adipocytes in vitro. As CL 168 might induce the expression of thermogenic or β-oxidation genes in adipocytes in 169 vitro, it was used as a positive control. Figure 2G and 2H show that IL-25 did not 170 augment the expression of thermogenic or β-oxidation genes such as Ucp1, Pgc-1α,
171
Acsl1 and Acox1 at various doses of treatment. Figure 3E shows that the IL-4-pretreated-Aps, rather than the IL-25-pretreated-Aps, 
IL-25 regulated adipose tissue innervation by macrophages 198
As blockade of IL-4Rα by its antibody did not entirely inhibit IL-25-induced 199 expression of UCP1 ( Figure 3G and 3H), we explored alternative mechanisms, i.e., To investigate whether IL-25 regulates its anti-obesity and anti-diabetic effects 249 through macrophages, we used DIO mice which were administered with 250 clodronate-loaded liposomes to deplete macrophages in adipose tissue without F4/80, 251 7 a marker of macrophage, expression ( Figure S4A ). Figure 6 shows that the 252 stimulatory effect of IL-25 on anti-diabetic was largely depended on macrophages.
253
IL-25 did not reduce fasting blood glucose ( Figure 6A ), or improve glucose tolerance 254 ( Figure 6B ) and insulin sensitivity ( Figure 6C ) in DIO mice treated with 255 clodronate-loaded liposomes. However, IL-25 reduced body weight gain ( Figure S4B ) 256 and eWAT mass ( Figure S4C ), lowered liver weight ( Figure S4D In this study, we identified that IL-25 signaling including IL-25 and its receptor Our study showed that both β3-agonist (1mg/kg body weight for 2 days) and 
309
Our study comprehensively explored the mechanism involving in the process of 
329
We found that blockade of IL-4Rα could not entirely inhibit IL-25-induced 330 expression of UCP1, suggesting that IL-25 also might participate the development of 331 beige fat with other mechanism. The fact that scWAT characterizes as prominent 
